Diosbulbin B aggravates doxorubicin-induced hepatotoxicity with PI3K/AKT signaling and redox-inflammatory stress responses
ObjectiveThis study evaluated whether diosbulbin B (DB) affects doxorubicin (DOX)-induced hepatotoxicity.
ObjectiveThis study evaluated whether diosbulbin B (DB) affects doxorubicin (DOX)-induced hepatotoxicity.